| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |